India vs Laos: Average cost of drugs for extensively drug-resistant tuberculosis

India
1,203 constant 2022 US$
in 2024
Laos
1,250 constant 2022 US$
in 2024
India rank
39th
Laos rank
37th

Average cost of drugs for extensively drug-resistant tuberculosis over time

  • India
  • Laos
02.5k5.0k7.5k10.0k201720202024

How they compare

Laos currently reports 1,250 constant 2022 US$ against 1,203 constant 2022 US$ in India, a difference of 47 constant 2022 US$.

The two have swapped places 1 time across 7 shared years of data; in 2018 it was India ahead.

India ranks 39th and Laos ranks 37th of 56 countries.

India has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade India Laos Difference Ahead
2010s 5,000 constant 2022 US$ 1,250 constant 2022 US$ 3,750 constant 2022 US$ India
2020s 2,104 constant 2022 US$ 1,240 constant 2022 US$ 863.6 constant 2022 US$ India

Averages of every year both report within each decade.

Frequently asked questions

Which has higher average cost of drugs for extensively drug-resistant tuberculosis, India or Laos?
Laos, at 1,250 constant 2022 US$ against 1,203 constant 2022 US$ in India as of 2024.
What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between India and Laos?
47 constant 2022 US$, with Laos ahead.
How many years of comparable data are there for India and Laos?
7 years are reported by both, from 2018 to 2024.
How do India and Laos rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
India ranks 39th and Laos ranks 37th of 56 countries.
Where does this data come from?
WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Average cost of drugs for extensively drug-resistant tuberculosis
Unit
constant 2022 US$
Source
WHO (2025) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
56 places, 394 data points, 2017–2024
Last refreshed

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.